Fort Lauderdale Eye Institute | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-08		NCT04108156
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)	Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Active, not recruiting	Phase 3	2026-10-06		NCT06510816
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-02		NCT07449923
Extension Study for the Port Delivery System With Ranibizumab (Portal)	Neovascular Age-Related Macular Degeneration	Recruiting	Phase 3	2026-09-28		NCT03683251
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56	wet macular degeneration	Active, not recruiting	Phase 3	2026-09-03		NCT06683742
A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema	diabetic macular edema	Active, not recruiting	Phase 4	2026-08-25		NCT05224102